In the past decade, large drugmakers including Allergan, Gilead and Novartis, have spent billions of dollars acquiring or licensing medicines designed to treat NASH.
Big pharma must be sniffing around GENF now for sure. World leader in the field
I’m sure you can track the patent online. I was following something on an American site that updated again on the 12th December. I’m buying more today! This is so undervalued
Still well under the IPO price aswell. A gain of over 220% from these levels. Not to mention GENF being far ahead of all peers in this field! An absolute steel and a fantastic opportunity for all to get in and enjoy the journey of this revolutionary company GLA